Mobile cardiac telemetry market seen topping $1.7 billion by 2030

The mobile cardiac telemetry systems market is projected to grow from $1.06 billion in 2025 to $1.7 billion by 2030, driven by rising cardiovascular disease, arrhythmia cases and demand for remote monitoring. North America held the largest share in 2025 as healthcare providers increasingly shift to real-time, home-based cardiac care.

Why it matters: - Mobile cardiac telemetry is moving from a niche tool to a mainstream way to detect heart rhythm problems early. - The market’s growth reflects broader pressure on healthcare systems to monitor patients remotely and respond faster to cardiac events. - Rising cardiovascular disease rates make continuous monitoring more relevant for both diagnosis and ongoing management.

What happened: - The Business Research Company published a report on the mobile cardiac telemetry systems market on August 18, 2026. - The report values the market at $1.06 billion in 2025 and projects it will reach $1.16 billion in 2026. - The report forecasts the market will grow to $1.7 billion by 2030. - North America held the largest market share in 2025.

The details: - The market is expected to grow at a 10.0% CAGR from 2025 to 2026. - The report projects a 9.9% CAGR through 2030. - Growth drivers include increasing cardiovascular disease prevalence, more arrhythmia cases, limits of traditional Holter monitoring, an aging population and broader use of outpatient cardiac diagnostic tools. - Mobile cardiac telemetry systems continuously monitor heart rhythms in real time and automatically transmit data to centralized monitoring centers. - The systems are used to diagnose and manage arrhythmias and other heart-related conditions. - The report cites a January 2024 American Heart Association figure showing the U.S. age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000, up 4.0% from 224.4 in 2023. - The report includes regional analysis for Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - North America’s lead is linked to advanced healthcare infrastructure, stronger remote monitoring adoption and growing awareness of cardiac health management. - The report also highlights remote patient monitoring, home healthcare, continuous real-time cardiac data and digital cardiac care platforms as major trends. - Expected innovations include patch-based telemetry devices, better real-time arrhythmia detection and alert systems, and more long-term cardiac rhythm monitoring. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables. - The company offered a free sample report and a full report through the sample download page and the full market report.

Between the lines: - The forecast points to a healthcare market shifting toward earlier detection and continuous oversight rather than episodic testing. - The report’s emphasis on home-based and ambulatory care suggests vendors are competing on convenience, connectivity and speed of clinical response. - North America’s lead implies that reimbursement, infrastructure and digital adoption remain key advantages in telehealth-linked cardiac monitoring.

What's next: - The market is expected to keep expanding as remote monitoring becomes more embedded in routine cardiac care. - Growth will likely depend on how quickly providers adopt patch devices, alert systems and home-care workflows. - The report suggests demand for long-term rhythm monitoring will continue to rise as cardiovascular disease cases increase.

The bottom line: - Mobile cardiac telemetry is on a strong growth path, with the biggest gains tied to real-time monitoring, remote care and earlier intervention.